Ghany MG, Gara N. Quest for a cure for hepatitis C virus: the end is in sight. The Lancet. 2014; 384: 381-3.Ghany MG, Gara N. QUEST for a cure for hepatitis C virus: the end is in sight. Lancet 2014; 384: 381-383 [PMID: 24907223 DOI: 10.1016/S0140-6736(14)60807-2]...
Hepatitis B Surface Antibody Quantitative Hepatitis B Surface Antibody, Quantitative Test code(s) 8475 Question 1. What is the clinical indication for hepatitis B surface antibody quantitation? Question 2. What is the hepatitis B surface antibody? Question 3. How is the quantitative hepatitis B ...
This video is either unavailable or not supported in this browser Error Code: MEDIA_ERR_SRC_NOT_SUPPORTED Session ID: 2025-02-15:d4c202513d389d272e97d98e Player Element ID: Vbab88cfb_a6c3_4077_a082_6f947105a632_6098113340001 OK Close Modal DialogSAN ANTONIO...
VDJ gene segments were identified and aligned using IMGT/HighV-QUEST41. VDJ sequences were extracted to construct a personal immunoglobulin amino acid sequence library for MS/MS data- base search. Protein identification and quantification were performed using MaxQuant9. The intensities of iTRAQ ...
The current invention contributes to the quest for candidate molecules for treatment and/or curing and/or prevention of HCV infection. As the candidate molecules are anti-HCV antibodies, they can also be applied for diagnosing HCV infection. Unexpectedly, the anti-HCV antibodies of the invention ar...
Australia antigen and the quest for a hepatitis virus. Am J Dig Dis. 1969 Mar; 14 (3):189–194.Sutnick, A. I. , W. T. London and B. S. Blumberg 1969 Australia antigen and the quest for a hepatitis virus . Amer. J. Digestive Diseases , 14 : 189 ....
Cardiovascular risk of tenofovir disoproxil fuma-rate or tenofovir alafenamide in patients with chronic hepatitis B: More questions than an answerdoi:10.3350/cmh.2024.0115Pin-Nan ChengMing-Lung YuClinical & Molecular Hepatology
hepatitisCviruspeginterferonquestionnaireribavirinBackground and aim: There has so far been no questionnaire report on patients who were treated with peginterferon plus ribavirin (PEG IFN+RBV) therapy. The purpose of this study was to investigate the problems of this therapy by a questionnaire ...